Paper
RSC Advances
1
68, 6814; (c) P. Saha, M. A. Ali, P. Ghosh and
T. Punniyamurthy, Org. Biomol. Chem., 2010, 8, 5692.
8 (a) A. Rao, A. Chimirri, S. Ferro, A. M. Monforte, P. Monforte
following a similar procedure (0.18 g, 81%): H NMR (400 MHz,
CDCl3): 7.53 (d, J = 8.0 Hz, 1 H; Ar–H), 7.43 (s, 1 H; Ar–H), 7.24–
7.37 (m, 6 H; Ar–H), 6.87 (d, J = 8.0 Hz, 1 H; Ar–H), 4.39 (bs, 3 H;
NH); MS (APCI) m/z: 229.3 (M+H)+.16c
`
and M. Zappala, ARKIVOC, 2004, V, 147; (b) P. Salehi, M. Dabiri,
M. A. Zolfigol, S. Otokesh and M. T. Baghbanzadeh, Tetrahedron
Lett., 2006, 47, 2557; (c) R. Varala, A. Nasreen, R. Enugala and S.
R. T. Adapa, Tetrahedron Lett., 2007, 48, 69; (d) N. D. Kokare, J.
N. Sangshetti and D. B. Shinde, Synthesis, 2007, 2829; (e) H.
A. Oskooie, M. M. Heravi, A. Sadnia, F. K. Behbahani and
F. Janati, Chin. Chem. Lett., 2007, 18, 1357; (f) S. S. Pawar, D.
V. Dekhane, M. S. Shingare and S. N. Thore, Chin. Chem. Lett.,
2008, 19, 1055; (g) M. Dabiri, P. Salehi, M. Baghbanzadeh and
M. S. Nikcheh, Synth. Commun., 2008, 38, 4272; (h) K. Niknam,
M. A. Zolfigol and N. Safikhani, Synth. Commun., 2008, 38, 2919;
(i) J. -P. Wan, S. -F. Gan, J. -M. Wu and Y. Pan, Green Chem., 2009,
11, 1633; (j) A. A. Mohammadi, J. Azizian and N. Karimi,
Heterocycles, 2009, 78, 2337; (k) G. R. Jadhav, M. U. Shaikh, R.
P. Kale and C. H. Gill, Chin. Chem. Lett., 2009, 20, 535; (l)
D. Saha, A. Saha and B. C. Ranu, Green Chem., 2009, 11, 733; (m)
S. Das Sharma and D. Konwar, Synth. Commun., 2009, 39, 980;
(n) R. G. Jacob, L. G. Dutra, C. S. Radatz, S. R. Mendes, G. Perin
and E. J. Lenardao, Tetrahedron Lett., 2009, 50, 1495; (o)
K. Bahrami, M. K. Mohamma and A. Nejati, Green Chem., 2010,
12, 1237; (p) N. Khodabakhsh, M. A. Zolfigol and N. Safikhani,
Synth. Commun., 2008, 38, 2919; (q) J. S. Yadav, B. V. S. Reddy,
K. Premalatha and S. K. Shiva, Can. J. Chem., 2008, 86, 124; (r)
S. Perumal, S. Mariappan and S. Selvaraj, ARKIVOC, 2004, VIII,
46; (s) G. R. Jacob, G. L. Dutra, S. C. Radatz, R. S. Mendes,
G. Perin and J. E. Lenardao, Tetrahedron Lett., 2009, 50, 1495; (t)
M. Chakrabarty, R. Mukherjee, S. Karmakar and Y. Harigaya,
Monatsh. Chem., 2007, 138, 1279; (u) L.-J. Zhang, J. Xia, Y.-
Q. Zhou, H. Wang and S.-W. Wang, Synth. Commun., 2012, 42,
328; (v) S. Paul and B. Basu, Tetrahedron Lett., 2012, 53, 4130.
9 J. Potosky, Drug Discovery Today, 2005, 10, 115.
Note added after first publication
This article replaces the version published on 6th November
2012, which contained errors in the title.
Acknowledgements
DK and DNK thank CSIR, New Delhi for RA and SRF
respectively. RC and SKG thank UGC for SRF.
References
1 (a) Angiotensin II receptor antagonist: Y. Kohara, K. Kubo,
E. Imamiya, T. Wada, Y. Inada and T. Naka, J. Med. Chem., 1996,
39, 5228; (b) Antiviral: A. R. Porcari, R. V. Devivar, L. S. Kucera, J.
C. Drach and L. B. Townsend, J. Med. Chem., 1998, 41, 1252; (c)
Neuropeptide Y Y1 receptor antagonist: H. Zarrinmayeh, A.
M. Nunes, P. L. Ornstein, D. M. Zimmerman, M. B. Arnold, D.
A. Schober, S. L. Gackenheimer, R. F. Bruns, P. A. Hipskind, T.
C. Britton, B. E. Cantrell and D. R. Gehlert, J. Med. Chem., 1998,
41, 2709; (d) Factor Xa inhibitor: Z. S. Zhao, D. O. Arnaiz,
B. Griedel, S. Sakata, J. L. Dallas, M. Whitlow, L. Trinh, J. Post,
A. Liang, M. M. Morrissey and K. J. Shaw, Bioorg. Med. Chem.
Lett., 2000, 10, 963; (e) Antiallergic 5-Lipoxygenase inhibitor:
H. Nakano, T. Inoue, N. Kawasaki, H. Miyakata, H. Matsumoto,
T. Taguch, N. Inagaki, H. Nagai and T. Satog, Bioorg. Med.
¨
Chem., 2000, 8, 373; (f) Antibacterial: H. Goker, C. Ku¸s, D.
W. Boykin, S. Yildiz and N. Altanlar, Bioorg. Med. Chem., 2002,
10, 2589; (g) Antimicrobial: G. Ayhan-K|lc|gil and N. Altanlar,
¨
Farmaco, 2003, 58, 1345; (h) S. Ozden, D. Atabey, S. Yildiz and
¨
H. Goker, Bioorg. Med. Chem., 2005, 13, 1587; (i) Anti-Hepatitis C
10 (a) G. Ertl, Angew. Chem., Int. Ed., 2008, 47, 3524; (b) The
2007 Nobel Prize in Chemistry.
11 (a) K. Wilson and J. H. Clark, Pure Appl. Chem., 2000, 72,
virus agents: T. Ishida, T. Suzuki, S. Hirashima, K. Mizutani,
A. Yoshida, I. Ando, S. Ikeda, T. Adachi and H. Hashimoto,
Bioorg. Med. Chem. Lett., 2006, 16, 1859; (j) J. R. Hwu, R. Singha,
S. C. Hong, Y. H. Chang, A. R. Das, I. Vliegen, E. De Clercq and
J. Neyts, Antiviral Res., 2008, 77, 157; (k) Burkitt’s lymphoma
promotion inhibitors: M. M. Ramla, M. A. Omar, H. Tokuda and
H. I. El-Diwani, Bioorg. Med. Chem., 2007, 15, 6489; (l)
Antimicrobial and antiviral agents: D. Sharma,
B. Narasimhan, P. Kumar, V. Judge, R. Narang, E. De Clercq
and J. J. Balzarini, J. Enzyme Inhib. Med. Chem., 2009, 24, 1161;
´
1313; (b) A. Corma and H. Garcıa, Chem. Rev., 2003, 103,
4307; (c) J. K. Nørskov, T. Bligaard, J. Rossmeisl and C.
H. Christensen, Nat. Chem., 2009, 1, 37.
12 (a) The heterogeneous catalyst systems HClO4–SiO2 and HBF4–
SiO2 were/are not commercially available and were prepared and
used for the first time by Chakraborti et al.: A. K. Chakraborti and
R. Gulhane, Chem. Commun., 2003, 1896; (b) A. K. Chakraborti
and R. Gulhane, Tetrahedron Lett., 2003, 44, 3521; (c) A.
K. Chakraborti and R. Gulhane, Indian Patent, 248506; Date:
20-07-2011. Appl. No. 266/DEL/2003. Filing Date: 10-3-2003.
13 See supporting information.
14 (a) G. Sharma, R. Kumar and A. K. Chakraborti, J. Mol. Catal. A:
Chem., 2007, 263, 143; (b) S. V. Chankeshwara and A.
K. Chakraborti, J. Mol. Catal. A: Chem., 2006, 253, 198; (c) A.
K. Chakraborti, A. Kondaskar and S. Rudrawar, Tetrahedron, 2004,
60, 9085; (d) A. K. Chakraborti, S. Rudrawar and A. Kondaskar,
Org. Biomol. Chem., 2004, 2, 1277.
´
(m) Antiparasitic agents: J. Perez-Villanueva, R. Santos,
´
A. Hernandez-Campos, M. A. Giulianotti, R. Castillo and J.
L. Medina-Franco, Med. Chem. Commun., 2011, 2, 44.
2 (a) A. Mazurov, Bioorg. Med. Chem. Lett., 2000, 10, 67; (b)
D. Tumelty, M. K. Schwarz and M. C. Needels, Tetrahedron
Lett., 1998, 39, 7467 and the references therein.
ˇ´
3 (a) J. M. Smith and V. Krchnak, Tetrahedron Lett., 1999, 40,
7633; (b) D. Vourloumis, M. Takahashi, K. B. Simonsen, B.
K. Ayida, S. Barluenga, G. C. Winters and T. Hermann,
Tetrahedron Lett., 2003, 44, 2807.
15 S. Dalapati, S. Jana, R. Saha, M. A. Alam and N. Guchhait,
Org. Lett., 2012, 14, 3244.
4 J. Ezquerra and C. Lamas, Tetrahedron, 1997, 53, 12755.
5 N. Zheng and S. L. Buchwald, Org. Lett., 2007, 9, 4749.
6 (a) B. Zou, Q. Yuan and D. Ma, Angew. Chem., Int. Ed., 2007, 46,
2598; (b) N. Zheng, K. W. Anderson, X. Huang, N. H. Nguyen
and S. L. Buchwald, Angew. Chem., Int. Ed., 2007, 46, 7509.
7 (a) C. T. Brain and S. A. Brunton, Tetrahedron Lett., 2002,
43, 1893; (b) C. T. Brain and J. T. Steer, J. Org. Chem., 2003,
16 (a) A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C.
A. Maryanoff and R. D. Shah, J. Org. Chem., 1996, 61, 3849;
(b) X. Yang, L. Zhao, T. Fox, Z.-X. Wang and H. Berke,
Angew. Chem., Int. Ed., 2010, 49, 2058; (c) M. Yang and
F. Liu, J. Org. Chem., 2007, 72, 8969.
98 | RSC Adv., 2013, 3, 91–98
This journal is ß The Royal Society of Chemistry 2013